At Close: Dec 08, 2023
Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript09:25pm, Monday, 13'th Nov 2023
Harrow, Inc. (NASDAQ:HROW ) Q3 2023 Earnings Conference Call November 13, 2023 4:45 PM ET Corporate Participants Jamie Webb - Director-Communications & Investor Relations Mark Baum - Chief Executive O
Harrow Health, Inc. (HROW) Q2 2023 Earnings Call Transcript10:35pm, Wednesday, 09'th Aug 2023
Harrow Health, Inc. (NASDAQ:HROW ) Q2 2023 Earnings Conference Call August 9, 2023 4:45 PM ET Company Participants Jamie Webb - Director-Communications & Investor Relations Mark L. Baum - Chief Execut
Harrow Health And Its Interesting 11.6% 2027 Baby Bond11:00am, Tuesday, 01'st Aug 2023
Harrow Health is an eye care pharmaceuticals company. The common stock has been on fire with expectations of rapidly increasing profits. HROW has 2 baby bonds, with one looking particularly interestin
Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?12:09pm, Thursday, 20'th Jul 2023
Harrow (HROW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Harrow Health (HROW) Flat As Market Sinks: What You Should Know07:25pm, Friday, 23'rd Jun 2023
Harrow Health (HROW) closed at $18.52 in the latest trading session, marking no change from the prior day.
Analysts Initiate Coverage: 5 Stocks for Higher Returns12:55pm, Monday, 15'th May 2023
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like MicroStrategy (MSTR), SPX Technologies (SPXC), Cvent (CVT), Harrow Health (HROW) and Banco (BM
Harrow Health, Inc. (HROW) Q1 2023 Earnings Call Transcript09:43pm, Thursday, 11'th May 2023
Harrow Health, Inc. (NASDAQ:HROW ) Q1 2023 Earnings Conference Call May 11, 2023 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew
Harrow Health (HROW) Reports Q1 Loss, Tops Revenue Estimates07:02pm, Thursday, 11'th May 2023
Harrow Health (HROW) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.03 per share a year ago.
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?01:43pm, Monday, 08'th May 2023
Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.
5 Stocks With Recent Price Strength That Still Have Upside08:22am, Wednesday, 03'rd May 2023
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.